GlassScriptPhysician profile
Sarah J Lee
NPI 1700923042
$734.14
in general payments reported to CMS, 2019-2025
17 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $12.43 · 2021: $51.81 · 2023: $13.60 · 2024: $108 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217 · Education: $13.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.27 |
| Education | $13.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $139.29 | 2019 | |
| Alexion Pharmaceuticals, INC. | $123.16 | 2019-2024 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $69.25 | 2019 | |
| Teleflex LLC | $62.21 | 2025 | Arrow |
| Opko Pharmaceuticals, LLC | $58.89 | 2019 | |
| Amag Pharmaceuticals, INC. | $51.81 | 2021 | |
| Akebia Therapeutics INC | $28.90 | 2019-2020 | |
| Ardelyx, INC. | $25.44 | 2025 | Ibsrela |
| Mallinckrodt Enterprises LLC | $24.79 | 2019 | |
| Daiichi Sankyo INC. | $24.09 | 2019 | |
| Scpharmaceuticals INC. | $21.87 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $20.07 | 2019 | |
| Fresenius USA Marketing, INC. | $18.21 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.00 | 2019 | |
| Amgen INC. | $17.95 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $16.61 | 2019 | |
| Calliditas Therapeutics US INC. | $13.60 | 2023 | Tarpeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.